Navigation Links
Cell Genesys to Present at the Cowen and Company and the Lehman Brothers Healthcare Investor Conferences
Date:3/11/2008

SOUTH SAN FRANCISCO, Calif., March 11 /PRNewswire-FirstCall/ -- Cell Genesys, Inc. (Nasdaq: CEGE) today announced that Sharon E. Tetlow, senior vice president and chief financial officer of Cell Genesys, will present a company update on Tuesday, March 18 at 8:00 a.m. ET at the Cowen and Company 28th Annual Healthcare Conference in Boston, Massachusetts. Stephen A. Sherwin, chairman and chief executive officer of Cell Genesys, will present a company update on March 18 at 10:15 a.m. ET at the Lehman Brothers 11th Annual Global Healthcare Conference in Miami, Florida.

A live audio webcast of both presentations will be accessible through the Investor Relations section of the Cell Genesys website, http://www.cellgenesys.com. If you are unable to listen to the live webcast, it will be archived on the site for at least 72 hours following the presentation. To access the replay, go to the Investor Relations section of the website.

Cell Genesys is focused on the development and commercialization of novel biological therapies for patients with cancer. The company is currently pursuing two clinical stage product platforms -- GVAX(TM) cancer immunotherapies and oncolytic virus therapies. Ongoing clinical trials include Phase 3 trials of GVAX immunotherapy for prostate cancer, Phase 2 trials of GVAX immunotherapies for pancreatic cancer and for leukemia, and a Phase 1 trial of CG0070 oncolytic virus therapy for bladder cancer. Cell Genesys continues to hold an equity interest in its former subsidiary, Ceregene, Inc., which is developing gene therapies for neurodegenerative disorders. Cell Genesys is headquartered in South San Francisco, CA and has its principal manufacturing operation in Hayward, CA. For additional information, please visit the company's website at http://www.cellgenesys.com.

Contact:

Susan Ferris

Investor Relations

650-266-3200


'/>"/>
SOURCE Cell Genesys, Inc.
Copyright©2008 PR Newswire.
All rights reserved

Related medicine news :

1. Cell Genesys Reports Fourth Quarter and Year-End 2007 Results
2. Brookdale to Present at Citi Small & Mid-Cap Conference on March 17
3. Schering-Plough to Webcast Presentation by CEO Fred Hassan at Lehman Brothers Eleventh Annual Global Healthcare Conference
4. Medco to Present at Cowen and Company and Lehman Brothers Health Care Conferences
5. Gentiva(R) Health Services to Present March 18th at Lehman Brothers Eleventh Annual Global Healthcare Conference in Miami
6. Thermo Fisher Scientific to Present at 11th Annual Lehman Brothers Global Healthcare Conference
7. AMN Healthcare Services to Present at the Lehman Brothers 11th Annual Global Healthcare Conference
8. Cowen & Company 28th Annual Healthcare Conference to Webcast Millennium Presentation
9. NBTY to Webcast Presentation at Bank of America Consumer Conference: Announces Preliminary Sales and the Repurchase of 6.1 Million Shares
10. Bi-Partisan Members of U.S. House of Representatives Formally Oppose Funding Reductions to Medicares Home Oxygen Benefit
11. Novavax CEO to Present at the Partnering for Global Health Forum
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:4/26/2017)... (PRWEB) , ... April 26, 2017 , ... ... Women's Excellence specializes in pelvic conditions and has helped many women become ... Excellence uses a combination of office-based and simple outpatient evaluations. We can ...
(Date:4/26/2017)... ... ... RawTrition now brings you BioEnergy which is a powder capsule whole food ... RawTrition is taking nutrients to the next level! The superfoods in RawTrition's BioEnergy ... (unlike the synthetically made options that are on the market). , Founder of RawTrition, ...
(Date:4/26/2017)... ... 2017 , ... New SUPRO® XT55 Isolated Soy Protein ... helping beverage manufacturers more effectively manage protein costs. “Soy protein has always been ... as more stable pricing over time. Now it’s even more relevant as plant ...
(Date:4/26/2017)... ... 2017 , ... MYOLYN, a medical technology company dedicated to ... 510(k) clearance from the U.S. Food & Drug Administration (FDA) for two of ... are stationary cycling systems that use MYOLYN’s patent-pending functional electrical stimulation (FES) ...
(Date:4/25/2017)... , ... April 25, 2017 , ... ... and collaboration, announces Mirroring360 Pro . This new addition to the Mirroring360 ... experience for education and business. , Mirroring360 Pro enables educators, business professionals and ...
Breaking Medicine News(10 mins):
(Date:4/24/2017)... UNION CITY, Calif. , April 24, 2017 /PRNewswire/ ... providing durability, grip, protection, and comfort, announces the release ... the Powerform S8+. This most recent example of leading ... high density grip pattern for 200% more tactile grip ... in user protection and durability. With TracTek and a ...
(Date:4/21/2017)... -- Halo Labs announces the launch of a novel ... the Horizon at PEGS 2017 in Boston ... sub visible particulate matter in biopharmaceutical samples to enable ... as candidate selection and pre-formulation. Halo Labs ... Elion Labs for system validation. "We are ...
(Date:4/20/2017)... -- Vivify Health, the pioneer and market leader of remote ... significant patent for the advancement of healthcare delivery from ... health.  This landmark patent provides the company with broad ... position as the leader in remote care.  ... to apply consumer mobile devices, wireless biometrics, EMR integration ...
Breaking Medicine Technology: